1-20 of 26
Daniel F. Hayes
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

A Randomized Trial of Fulvestrant, Everolimus, and Anastrozole for the Front-line Treatment of Patients with Advanced Hormone Receptor–positive Breast Cancer, SWOG S1222

Halle C.F. Moore, William E. Barlow, George Somlo, Julie R. Gralow, Anne F. Schott, Daniel F. Hayes, Peter Kuhn, James B. Hicks, Lisa Welter, Philip A. Dy, Christina H. Yeon, Alison K. Conlin, Ernie Balcueva, Danika L. Lew, Debasish Tripathy, Lajos Pusztai, Gabriel N. Hortobagyi
Journal: Clinical Cancer Research
Clin Cancer Res (2022) 28 (4): 611–617.
https://doi.org/10.1158/1078-0432.CCR-21-3131
Published: 15 February 2022
View article titled, A Randomized Trial of Fulvestrant, Everolimus, and Anastrozole for the Front-line Treatment of Patients with Advanced Hormone Receptor–positive Breast Cancer, SWOG S1222
Open the PDF for A Randomized Trial of Fulvestrant, Everolimus, and Anastrozole for the Front-line Treatment of Patients with Advanced Hormone Receptor–positive Breast Cancer, SWOG S1222 in another window
Includes: Supplementary data
Journal Articles

Evaluating Serum Thymidine Kinase 1 in Patients with Hormone Receptor–Positive Metastatic Breast Cancer Receiving First-line Endocrine Therapy in the SWOG S0226 Trial

Costanza Paoletti, William E. Barlow, Erin F. Cobain, Mattias Bergqvist, Rita S. Mehta, Julie R. Gralow, Gabriel N. Hortobagyi, Kathy S. Albain, Lajos Pusztai, Priyanka Sharma, Andrew K. Godwin, Alastair M. Thompson, Daniel F. Hayes, James M. Rae
Journal: Clinical Cancer Research
Clin Cancer Res (2021) 27 (22): 6115–6123.
https://doi.org/10.1158/1078-0432.CCR-21-1562
Published: 15 November 2021
View article titled, Evaluating Serum Thymidine Kinase 1 in Patients with Hormone Receptor–Positive Metastatic Breast Cancer Receiving First-line Endocrine Therapy in the SWOG S0226 Trial
Open the PDF for Evaluating Serum Thymidine Kinase 1 in Patients with Hormone Receptor–Positive Metastatic Breast Cancer Receiving First-line Endocrine Therapy in the SWOG S0226 Trial in another window
Includes: Supplementary data
Journal Articles

Circulating Tumor Cell Clusters in Patients with Metastatic Breast Cancer: a SWOG S0500 Translational Medicine Study

Costanza Paoletti, Jieling Miao, Emily M. Dolce, Elizabeth P. Darga, Madeline I. Repollet, Gerald V. Doyle, Julie R. Gralow, Gabriel N. Hortobagyi, Jeffrey B. Smerage, William E. Barlow, Daniel F. Hayes
Journal: Clinical Cancer Research
Clin Cancer Res (2019) 25 (20): 6089–6097.
https://doi.org/10.1158/1078-0432.CCR-19-0208
Published: 15 October 2019
View article titled, Circulating Tumor Cell Clusters in Patients with Metastatic Breast Cancer: a SWOG S0500 Translational Medicine Study
Open the PDF for Circulating Tumor Cell Clusters in Patients with Metastatic Breast Cancer: a SWOG S0500 Translational Medicine Study in another window
Includes: Supplementary data
Journal Articles

Circulating Biomarkers and Resistance to Endocrine Therapy in Metastatic Breast Cancers: Correlative Results from AZD9496 Oral SERD Phase I Trial

Costanza Paoletti, Gaia Schiavon, Emily M. Dolce, Elizabeth P. Darga, T. Hedley Carr, Joseph Geradts, Matthias Hoch, Teresa Klinowska, Justin Lindemann, Gayle Marshall, Shethah Morgan, Parul Patel, Vicky Rowlands, Nitharsan Sathiyayogan, Kimberly Aung, Erika Hamilton, Manish Patel, Anne Armstrong, Komal Jhaveri, Seock-Ah Im, Nadia Iqbal, Fouziah Butt, Caroline Dive, Elizabeth A. Harrington, J. Carl Barrett, Richard Baird, Daniel F. Hayes
Journal: Clinical Cancer Research
Series: Author Choice
Clin Cancer Res (2018) 24 (23): 5860–5872.
https://doi.org/10.1158/1078-0432.CCR-18-1569
Published: 03 December 2018
View article titled, Circulating Biomarkers and Resistance to Endocrine Therapy in Metastatic Breast Cancers: Correlative Results from AZD9496 Oral SERD Phase I Trial
Open the PDF for Circulating Biomarkers and Resistance to Endocrine Therapy in Metastatic Breast Cancers: Correlative Results from AZD9496 Oral SERD Phase I Trial in another window
Includes: Supplementary data
Journal Articles

Paclitaxel Plasma Concentration after the First Infusion Predicts Treatment-Limiting Peripheral Neuropathy

Daniel L. Hertz, Kelley M. Kidwell, Kiran Vangipuram, Feng Li, Manjunath P. Pai, Monika Burness, Jennifer J. Griggs, Anne F. Schott, Catherine Van Poznak, Daniel F. Hayes, Ellen M. Lavoie Smith, N. Lynn Henry
Journal: Clinical Cancer Research
Clin Cancer Res (2018) 24 (15): 3602–3610.
https://doi.org/10.1158/1078-0432.CCR-18-0656
Published: 31 July 2018
View article titled, Paclitaxel Plasma Concentration after the First Infusion Predicts Treatment-Limiting Peripheral Neuropathy
Open the PDF for Paclitaxel Plasma Concentration after the First Infusion Predicts Treatment-Limiting Peripheral Neuropathy in another window
Includes: Supplementary data
Journal Articles

Neratinib Efficacy and Circulating Tumor DNA Detection of HER2 Mutations in HER2 Nonamplified Metastatic Breast Cancer

Cynthia X. Ma, Ron Bose, Feng Gao, Rachel A. Freedman, Melinda L. Telli, Gretchen Kimmick, Eric Winer, Michael Naughton, Matthew P. Goetz, Christy Russell, Debu Tripathy, Melody Cobleigh, Andres Forero, Timothy J. Pluard, Carey Anders, Polly Ann Niravath, Shana Thomas, Jill Anderson, Caroline Bumb, Kimberly C. Banks, Richard B. Lanman, Richard Bryce, Alshad S. Lalani, John Pfeifer, Daniel F. Hayes, Mark Pegram, Kimberly Blackwell, Philippe L. Bedard, Hussam Al-Kateb, Matthew J.C. Ellis
Journal: Clinical Cancer Research
Clin Cancer Res (2017) 23 (19): 5687–5695.
https://doi.org/10.1158/1078-0432.CCR-17-0900
Published: 01 October 2017
View article titled, Neratinib Efficacy and Circulating Tumor DNA Detection of <em>HER2</em> Mutations in <em>HER2</em> Nonamplified Metastatic Breast Cancer
Open the PDF for Neratinib Efficacy and Circulating Tumor DNA Detection of <em>HER2</em> Mutations in <em>HER2</em> Nonamplified Metastatic Breast Cancer in another window
Includes: Supplementary data
Journal Articles

Maternal Embryonic Leucine Zipper Kinase (MELK) as a Novel Mediator and Biomarker of Radioresistance in Human Breast Cancer

Corey Speers, Shuang G. Zhao, Vishal Kothari, Alyssa Santola, Meilan Liu, Kari Wilder-Romans, Joseph Evans, Nidhi Batra, Harry Bartelink, Daniel F. Hayes, Theodore S. Lawrence, Powel H. Brown, Lori J. Pierce, Felix Y. Feng
Journal: Clinical Cancer Research
Series: Author Choice
Clin Cancer Res (2016) 22 (23): 5864–5875.
https://doi.org/10.1158/1078-0432.CCR-15-2711
Published: 30 November 2016
View article titled, Maternal Embryonic Leucine Zipper Kinase (MELK) as a Novel Mediator and Biomarker of Radioresistance in Human Breast Cancer
Open the PDF for Maternal Embryonic Leucine Zipper Kinase (MELK) as a Novel Mediator and Biomarker of Radioresistance in Human Breast Cancer in another window
Includes: Supplementary data
Journal Articles

Association of Variants in Candidate Genes with Lipid Profiles in Women with Early Breast Cancer on Adjuvant Aromatase Inhibitor Therapy

Cesar A. Santa-Maria, Amanda Blackford, Anne T. Nguyen, Todd C. Skaar, Santosh Philips, Steffi Oesterreich, James M. Rae, Zeruesenay Desta, Jason Robarge, Norah Lynn Henry, Anna M. Storniolo, Daniel F. Hayes, Roger S. Blumenthal, Pamela Ouyang, Wendy S. Post, David A. Flockhart, Vered Stearns
Journal: Clinical Cancer Research
Clin Cancer Res (2016) 22 (6): 1395–1402.
https://doi.org/10.1158/1078-0432.CCR-15-1213
Published: 14 March 2016
View article titled, Association of Variants in Candidate Genes with Lipid Profiles in Women with Early Breast Cancer on Adjuvant Aromatase Inhibitor Therapy
Open the PDF for Association of Variants in Candidate Genes with Lipid Profiles in Women with Early Breast Cancer on Adjuvant Aromatase Inhibitor Therapy in another window
Includes: Supplementary data
Journal Articles

ESR1 Mutations in Circulating Plasma Tumor DNA from Metastatic Breast Cancer Patients

David Chu, Costanza Paoletti, Christina Gersch, Dustin A. VanDenBerg, Daniel J. Zabransky, Rory L. Cochran, Hong Yuen Wong, Patricia Valda Toro, Justin Cidado, Sarah Croessmann, Bracha Erlanger, Karen Cravero, Kelly Kyker-Snowman, Berry Button, Heather A. Parsons, W. Brian Dalton, Riaz Gillani, Arielle Medford, Kimberly Aung, Nahomi Tokudome, Arul M. Chinnaiyan, Anne Schott, Dan Robinson, Karen S. Jacks, Josh Lauring, Paula J. Hurley, Daniel F. Hayes, James M. Rae, Ben Ho Park
Journal: Clinical Cancer Research
Clin Cancer Res (2016) 22 (4): 993–999.
https://doi.org/10.1158/1078-0432.CCR-15-0943
Published: 14 February 2016
View article titled, <em>ESR1</em> Mutations in Circulating Plasma Tumor DNA from Metastatic Breast Cancer Patients
Open the PDF for <em>ESR1</em> Mutations in Circulating Plasma Tumor DNA from Metastatic Breast Cancer Patients in another window
Includes: Supplementary data
Journal Articles

Significance of Circulating Tumor Cells in Metastatic Triple-Negative Breast Cancer Patients within a Randomized, Phase II Trial: TBCRC 019

Costanza Paoletti, Yufeng Li, Maria C. Muñiz, Kelley M. Kidwell, Kimberly Aung, Dafydd G. Thomas, Martha E. Brown, Vandana G. Abramson, William J. Irvin, Jr, Nancy U. Lin, Minetta C. Liu, Rita Nanda, Julie R. Nangia, Anna M. Storniolo, Tiffany A. Traina, Christos Vaklavas, Catherine H. Van Poznak, Antonio C. Wolff, Andres Forero-Torres, Daniel F. Hayes
Journal: Clinical Cancer Research
Clin Cancer Res (2015) 21 (12): 2771–2779.
https://doi.org/10.1158/1078-0432.CCR-14-2781
Published: 14 June 2015
View article titled, Significance of Circulating Tumor Cells in Metastatic Triple-Negative Breast Cancer Patients within a Randomized, Phase II Trial: TBCRC 019
Open the PDF for Significance of Circulating Tumor Cells in Metastatic Triple-Negative Breast Cancer Patients within a Randomized, Phase II Trial: TBCRC 019 in another window
Includes: Supplementary data
Journal Articles

Development of Circulating Tumor Cell-Endocrine Therapy Index in Patients with Hormone Receptor–Positive Breast Cancer

Costanza Paoletti, Maria C. Muñiz, Dafydd G. Thomas, Kent A. Griffith, Kelley M. Kidwell, Nahomi Tokudome, Martha E. Brown, Kimberly Aung, M. Craig Miller, Dorothy L. Blossom, Anne F. Schott, N. Lynn Henry, James M. Rae, Mark C. Connelly, David A. Chianese, Daniel F. Hayes
Journal: Clinical Cancer Research
Clin Cancer Res (2015) 21 (11): 2487–2498.
https://doi.org/10.1158/1078-0432.CCR-14-1913
Published: 31 May 2015
View article titled, Development of Circulating Tumor Cell-Endocrine Therapy Index in Patients with Hormone Receptor–Positive Breast Cancer
Open the PDF for Development of Circulating Tumor Cell-Endocrine Therapy Index in Patients with Hormone Receptor–Positive Breast Cancer in another window
Includes: Supplementary data
Journal Articles

Preclinical and Clinical Studies of Gamma Secretase Inhibitors with Docetaxel on Human Breast Tumors

Anne F. Schott, Melissa D. Landis, Gabriela Dontu, Kent A. Griffith, Rachel M. Layman, Ian Krop, Lacey A. Paskett, Helen Wong, Lacey E. Dobrolecki, Michael T. Lewis, Amber M. Froehlich, Jaya Paranilam, Daniel F. Hayes, Max S. Wicha, Jenny C. Chang
Journal: Clinical Cancer Research
Clin Cancer Res (2013) 19 (6): 1512–1524.
https://doi.org/10.1158/1078-0432.CCR-11-3326
Published: 14 March 2013
View article titled, Preclinical and Clinical Studies of Gamma Secretase Inhibitors with Docetaxel on Human Breast Tumors
Open the PDF for Preclinical and Clinical Studies of Gamma Secretase Inhibitors with Docetaxel on Human Breast Tumors in another window
Includes: Supplementary data
Journal Articles

p53 Expression in Node-Positive Breast Cancer Patients: Results from the Cancer and Leukemia Group B 9344 Trial (159905)

Jonathan F. Lara, Ann D. Thor, Lynn G. Dressler, Gloria Broadwater, Ira J. Bleiweiss, Susan Edgerton, David Cowan, Lori J. Goldstein, Silvana Martino, James N. Ingle, I. Craig Henderson, Larry Norton, Eric P. Winer, Clifford A. Hudis, Matthew J. Ellis, Donald A. Berry, Daniel F. Hayes, for the Cancer and Leukemia Group B
Journal: Clinical Cancer Research
Clin Cancer Res (2011) 17 (15): 5170–5178.
https://doi.org/10.1158/1078-0432.CCR-11-0484
Published: 31 July 2011
View article titled, p53 Expression in Node-Positive Breast Cancer Patients: Results from the Cancer and Leukemia Group B 9344 Trial (159905)
Open the PDF for p53 Expression in Node-Positive Breast Cancer Patients: Results from the Cancer and Leukemia Group B 9344 Trial (159905) in another window
Journal Articles

Gene Polymorphisms in Cyclophosphamide Metabolism Pathway,Treatment-Related Toxicity, and Disease-Free Survival in SWOG 8897 Clinical Trial for Breast Cancer

Song Yao, William E. Barlow, Kathy S. Albain, Ji-Yeob Choi, Hua Zhao, Robert B. Livingston, Warren Davis, James M. Rae, I-Tien Yeh, Laura F. Hutchins, Peter M. Ravdin, Silvana Martino, Alan P. Lyss, C. Kent Osborne, Martin Abeloff, Gabriel N. Hortobagyi, Daniel F. Hayes, Christine B. Ambrosone
Journal: Clinical Cancer Research
Clin Cancer Res (2010) 16 (24): 6169–6176.
https://doi.org/10.1158/1078-0432.CCR-10-0281
Published: 16 December 2010
View article titled, Gene Polymorphisms in Cyclophosphamide Metabolism Pathway,Treatment-Related Toxicity, and Disease-Free Survival in SWOG 8897 Clinical Trial for Breast Cancer
Open the PDF for Gene Polymorphisms in Cyclophosphamide Metabolism Pathway,Treatment-Related Toxicity, and Disease-Free Survival in SWOG 8897 Clinical Trial for Breast Cancer in another window
Journal Articles

Report from the Radiation Therapy Committee of the Southwest Oncology Group (SWOG): Research Objectives Workshop 2008

Paul Okunieff, Lisa A. Kachnic, Louis S. Constine, Clifton D. Fuller, Laurie E. Gaspar, Daniel F. Hayes, Jean Hooks, Clifton Ling, Frank L. Meyskens, Jr., Philip A. Philip, David Raben, Stephen R. Smalley, Gregory P. Swanson, Beverly A. Teicher, Charles R. Thomas, Jr., Bhadrasain Vikram, Michael J. Zelefsky, Laurence H. Baker
Journal: Clinical Cancer Research
Clin Cancer Res (2009) 15 (18): 5663–5670.
https://doi.org/10.1158/1078-0432.CCR-09-0357
Published: 14 September 2009
View article titled, Report from the Radiation Therapy Committee of the Southwest Oncology Group (SWOG): Research Objectives Workshop 2008
Open the PDF for Report from the Radiation Therapy Committee of the Southwest Oncology Group (SWOG): Research Objectives Workshop 2008 in another window
Journal Articles

Nitric Oxide Synthase Variants and Disease-Free Survival among Treated and Untreated Breast Cancer Patients in a Southwest Oncology Group Clinical Trial

Ji-Yeob Choi, William E. Barlow, Kathy S. Albain, Chi-Chen Hong, Javier G. Blanco, Robert B. Livingston, Warren Davis, James M. Rae, I-Tien Yeh, Laura F. Hutchins, Peter M. Ravdin, Silvana Martino, Alan P. Lyss, C. Kent Osborne, Martin D. Abeloff, Daniel F. Hayes, Christine B. Ambrosone
Journal: Clinical Cancer Research
Clin Cancer Res (2009) 15 (16): 5258–5266.
https://doi.org/10.1158/1078-0432.CCR-09-0685
Published: 12 August 2009
View article titled, Nitric Oxide Synthase Variants and Disease-Free Survival among Treated and Untreated Breast Cancer Patients in a Southwest Oncology Group Clinical Trial
Open the PDF for Nitric Oxide Synthase Variants and Disease-Free Survival among Treated and Untreated Breast Cancer Patients in a Southwest Oncology Group Clinical Trial in another window
Journal Articles

Is There a Role for Circulating Tumor Cells in the Management of Breast Cancer?

Daniel F. Hayes, Jeffrey Smerage
Journal: Clinical Cancer Research
Clin Cancer Res (2008) 14 (12): 3646–3650.
https://doi.org/10.1158/1078-0432.CCR-07-4481
Published: 16 June 2008
View article titled, Is There a Role for Circulating Tumor Cells in the Management of Breast Cancer?
Open the PDF for Is There a Role for Circulating Tumor Cells in the Management of Breast Cancer? in another window
Journal Articles

Neoadjuvant Docetaxel and Capecitabine and the Use of Thymidine Phosphorylase as a Predictive Biomarker in Breast Cancer

Rachel M. Layman, Dafydd G. Thomas, Kent A. Griffith, Jeffrey B. Smerage, Mark A. Helvie, Marilyn A. Roubidoux, Kathleen M. Diehl, Lisa A. Newman, Michael S. Sabel, James A. Hayman, Lori J. Pierce, Daniel F. Hayes, Anne F. Schott
Journal: Clinical Cancer Research
Clin Cancer Res (2007) 13 (14): 4092–4097.
https://doi.org/10.1158/1078-0432.CCR-07-0288
Published: 18 July 2007
View article titled, Neoadjuvant Docetaxel and Capecitabine and the Use of Thymidine Phosphorylase as a Predictive Biomarker in Breast Cancer
Open the PDF for Neoadjuvant Docetaxel and Capecitabine and the Use of Thymidine Phosphorylase as a Predictive Biomarker in Breast Cancer in another window
Journal Articles

Circulating Tumor Cells versus Imaging—Predicting Overall Survival in Metastatic Breast Cancer

G. Thomas Budd, Massimo Cristofanilli, Mathew J. Ellis, Allison Stopeck, Ernest Borden, M. Craig Miller, Jeri Matera, Madeline Repollet, Gerald V. Doyle, Leon W.M.M. Terstappen, Daniel F. Hayes
Journal: Clinical Cancer Research
Clin Cancer Res (2006) 12 (21): 6403–6409.
https://doi.org/10.1158/1078-0432.CCR-05-1769
Published: 03 November 2006
View article titled, Circulating Tumor Cells versus Imaging—Predicting Overall Survival in Metastatic Breast Cancer
Open the PDF for Circulating Tumor Cells versus Imaging—Predicting Overall Survival in Metastatic Breast Cancer in another window
Journal Articles

Circulating Tumor Cells at Each Follow-up Time Point during Therapy of Metastatic Breast Cancer Patients Predict Progression-Free and Overall Survival

Daniel F. Hayes, Massimo Cristofanilli, G. Thomas Budd, Matthew J. Ellis, Alison Stopeck, M. Craig Miller, Jeri Matera, W. Jeffrey Allard, Gerald V. Doyle, Leon W.W.M. Terstappen
Journal: Clinical Cancer Research
Clin Cancer Res (2006) 12 (14): 4218–4224.
https://doi.org/10.1158/1078-0432.CCR-05-2821
Published: 20 July 2006
View article titled, Circulating Tumor Cells at Each Follow-up Time Point during Therapy of Metastatic Breast Cancer Patients Predict Progression-Free and Overall Survival
Open the PDF for Circulating Tumor Cells at Each Follow-up Time Point during Therapy of Metastatic Breast Cancer Patients Predict Progression-Free and Overall Survival in another window